- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
LENSAR, TrueVision to integrate technologies
LENSAR and TrueVision 3D Surgical have made a global co-development and distribution agreement that integrates TruVision’s overlay and nomogram-the TrueGuide system-into LENSAR’s laser system’s advanced technology suite.
Orlando, FL and Santa Barbara, CA-LENSAR and TrueVision 3D Surgical have made a global co-development and distribution agreement that integrates TruVision’s overlay and nomogram-the TrueGuide system-into LENSAR’s laser system’s advanced technology suite.
“Surgeons using the laser system with our proprietary augmented reality image and guidance will now have the added benefit of TrueVision’s overlay and nomogram, which will be incorporated seamlessly into LENSAR’s efficient surgical suite,” said Nick Curtis, chief executive officer of LENSAR. “This deal is a continuation of our commitment to drive innovation and advance refractive cataract surgery.”
The laser system-which is an intelligent femtosecond cataract surgery laser that offers imaging, measurement, and 3-dimensional modeling technology-integrated with the nomogram, premiered last week at the American Society of Cataract/Refractive Surgery annual symposium and congress in Boston.
For more articles in this issue of Ophthalmology Times eReport, click here.
To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.
